CA97098/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2003	4
2004	2
2005	1
2006	3
2007	5
2008	2
2009	9
2010	3
2011	5
2012	7
2013	6
2014	7
2015	3
2016	1
2024	0

1

Mucins in cancer: function, prognosis and therapy.

Kufe DW. Kufe DW. Nat Rev Cancer. 2009 Dec;9(12):874-85. doi: 10.1038/nrc2761. Nat Rev Cancer. 2009. PMID: 19935676 Free PMC article. Review.

2

MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.

Kufe DW. Kufe DW. Oncogene. 2013 Feb 28;32(9):1073-81. doi: 10.1038/onc.2012.158. Epub 2012 May 14. Oncogene. 2013. PMID: 22580612 Free PMC article. Review.

3

Evolution of the human MUC1 oncoprotein.

Duraisamy S, Kufe T, Ramasamy S, Kufe D. Duraisamy S, et al. Int J Oncol. 2007 Sep;31(3):671-7. Int J Oncol. 2007. PMID: 17671696

4

Functional targeting of the MUC1 oncogene in human cancers.

Kufe DW. Kufe DW. Cancer Biol Ther. 2009 Jul;8(13):1197-203. doi: 10.4161/cbt.8.13.8844. Epub 2009 Jul 27. Cancer Biol Ther. 2009. PMID: 19556858 Free PMC article. Review. No abstract available.

5

MUC1-C activates the TAK1 inflammatory pathway in colon cancer.

Takahashi H, Jin C, Rajabi H, Pitroda S, Alam M, Ahmad R, Raina D, Hasegawa M, Suzuki Y, Tagde A, Bronson RT, Weichselbaum R, Kufe D. Takahashi H, et al. Oncogene. 2015 Oct 1;34(40):5187-97. doi: 10.1038/onc.2014.442. Epub 2015 Feb 9. Oncogene. 2015. PMID: 25659581 Free PMC article.

6

MUC1-C Induces the LIN28B→LET-7→HMGA2 Axis to Regulate Self-Renewal in NSCLC.

Alam M, Ahmad R, Rajabi H, Kufe D. Alam M, et al. Mol Cancer Res. 2015 Mar;13(3):449-60. doi: 10.1158/1541-7786.MCR-14-0363. Epub 2014 Nov 3. Mol Cancer Res. 2015. PMID: 25368430 Free PMC article.

7

A monoclonal antibody against the oncogenic mucin 1 cytoplasmic domain.

Panchamoorthy G, Rehan H, Kharbanda A, Ahmad R, Kufe D. Panchamoorthy G, et al. Hybridoma (Larchmt). 2011 Dec;30(6):531-5. doi: 10.1089/hyb.2011.0070. Hybridoma (Larchmt). 2011. PMID: 22149278 Free PMC article.

8

Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents.

Ren J, Agata N, Chen D, Li Y, Yu WH, Huang L, Raina D, Chen W, Kharbanda S, Kufe D. Ren J, et al. Cancer Cell. 2004 Feb;5(2):163-75. doi: 10.1016/s1535-6108(04)00020-0. Cancer Cell. 2004. PMID: 14998492 Free PMC article.

9

MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition.

Rajabi H, Alam M, Takahashi H, Kharbanda A, Guha M, Ahmad R, Kufe D. Rajabi H, et al. Oncogene. 2014 Mar 27;33(13):1680-9. doi: 10.1038/onc.2013.114. Epub 2013 Apr 15. Oncogene. 2014. PMID: 23584475 Free PMC article.

10

Oncogenic MUC1-C promotes tamoxifen resistance in human breast cancer.

Kharbanda A, Rajabi H, Jin C, Raina D, Kufe D. Kharbanda A, et al. Mol Cancer Res. 2013 Jul;11(7):714-23. doi: 10.1158/1541-7786.MCR-12-0668. Epub 2013 Mar 28. Mol Cancer Res. 2013. PMID: 23538857 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year